NM_000488.4:c.1376C>A
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2_SupportingPS4_SupportingPS3_SupportingPP3
This summary comes from the ClinGen Evidence Repository: The c.1376C>A variant in SERPINC1 is a missense variant predicted to cause substitution of alanine by aspartic acid at amino acid 459 (p.Ala459Asp). This variant has been reported in 2 probands meeting an antithrombin activity level of < 0.8 IU/mL. One proband had a family history of disease with reported antithrombin activity level and one proband had a family history of disease but no antithrombin activity level was reported (PS4_Supporting; PMIDs: 8401542, 23809926). This variant is absent from gnomAD v2.1.1, v3.1.2 and v4.1 (PM2_Supporting). The computational predictor REVEL gives a score of 0.756, which is above the threshold of 0.6, evidence that correlates with impact to SERPINC1 function (PP3). AT activity levels are shown to be reduced (27%) of WT when Ala459Asp was expressed in COS (PMID:23809926), meeting criteria for PS3_Supporting.In summary, this variant meets the criteria to be classified as uncertain significance due to insufficient evidence for autosomal dominant hereditary antithrombin deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen Thrombosis VCEP: PP3, PM2_Supporting, PS4_Supporting, PS3_Supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA343772066/MONDO:0013144/084
Frequency
Consequence
NM_000488.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SERPINC1 | NM_000488.4 | c.1376C>A | p.Ala459Asp | missense_variant | Exon 7 of 7 | ENST00000367698.4 | NP_000479.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary antithrombin deficiency Pathogenic:1Uncertain:1
The c.1376C>A variant in SERPINC1 is a missense variant predicted to cause substitution of alanine by aspartic acid at amino acid 459 (p.Ala459Asp). This variant has been reported in 2 probands meeting an antithrombin activity level of < 0.8 IU/mL. One proband had a family history of disease with reported antithrombin activity level and one proband had a family history of disease but no antithrombin activity level was reported (PS4_Supporting; PMIDs: 8401542, 23809926). This variant is absent from gnomAD v2.1.1, v3.1.2 and v4.1 (PM2_Supporting). The computational predictor REVEL gives a score of 0.756, which is above the threshold of 0.6, evidence that correlates with impact to SERPINC1 function (PP3). AT activity levels are shown to be reduced (27%) of WT when Ala459Asp was expressed in COS (PMID: 23809926), meeting criteria for PS3_Supporting. In summary, this variant meets the criteria to be classified as uncertain significance due to insufficient evidence for autosomal dominant hereditary antithrombin deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen Thrombosis VCEP: PP3, PM2_Supporting, PS4_Supporting, PS3_Supporting. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at